Home

Public Equity K/S NB

CIK 1451330 · last filed 2014-07-15

Public Equity K/S NB is a corporate insider who has filed 15 SEC Form 4 insider transactions across 2 companies since 2009. The most recent filing shows the insider sold $11.6M of QLTI on Jul 15, 2014. Across all open-market trades the lifetime net is −$8.5M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $177.7M across reported positions. 34 SEC filings were submitted jointly with QLT INC/BC.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$177.69M

Companies

2

Total Filings

15

Lifetime Open-Market Net

-$8.53M

Filer Profile

Reported Address
OESTERGADE 24A,1
DK-1100
COPENHAGEN, G7 -----
Phone
(457) 020-1263
Related Filers
QLT INC/BC — 34 joint filings, latest 2020-01-21
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
QLTI 10%+ Owner 6,447,626 $27.56 $177.69M -$9.67M 10 2014-07-15
Astex Pharmaceuticals, Inc (SUPG) Delisted 10%+ Owner 6,028,117 — — $1.15M 5 2010-04-26

Recent Filings

15 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2014-07-15 QLTI Sell (S) −2,000,000 -$11.60M EDGAR
2011-09-01 QLTI Sell (S) −389,961 -$2.83M EDGAR
2011-08-31 QLTI Sell (S) −600,000 -$4.25M EDGAR
2010-04-26 Astex Pharmaceuticals, Inc (SUPG) Delisted Sell (S) −345,000 -$1.07M EDGAR
2010-03-15 QLTI Buy (P) +390,534 $1.90M EDGAR
2009-09-02 Astex Pharmaceuticals, Inc (SUPG) Delisted Buy (P) +420,453 $1.19M EDGAR
2009-08-31 Astex Pharmaceuticals, Inc (SUPG) Delisted Buy (P) +32,850 $92.2K EDGAR
2009-08-21 Astex Pharmaceuticals, Inc (SUPG) Delisted Buy (P) +53,109 $142.0K EDGAR
2009-08-19 Astex Pharmaceuticals, Inc (SUPG) Delisted Buy (P) +306,066 $791.8K EDGAR
2009-04-16 QLTI Buy (P) +83,505 $193.9K EDGAR
Showing 1–10 of 15
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.